系统性红斑狼疮的神经精神症状:国际INSPIRE项目中患者来源归因证据的混合方法分析
该混合方法分析纳入2817名参与者(含400名临床医生),比较系统性红斑狼疮(SLE)患者、对照组和炎症性关节炎(IA)患者的神经精神症状归因。SLE患者(n=609)报告神经精神症状患病率显著高于对照组(n=463)和IA患者(n=489);幻觉和严重头痛在SLE中被评估为最直接可归因。
要点
- SLE患者中超过45%报告疲劳、阳性感觉症状、严重头痛和认知功能障碍在使用皮质类固醇后缓解或改善。
- SLE患者报告幻觉和严重头痛的直接可归因性证据最高。
- 临床医生和患者均报告没有足够时间讨论患者报告的归因证据。
核心结论
- 研究发现SLE患者中常见和既往未探索的神经精神症状具有不同程度的直接可归因性,其中幻觉和严重头痛被评估为最直接可归因。
- IA和其他系统性风湿病中对神经系统的直接效应可能存在目前被低估的情况。
研究设计与样本
- 定量与定性数据混合方法分析,纳入神经精神症状的患病率与频率、对皮质类固醇的反应以及神经精神症状与非神经精神SLE疾病活动的并发情况。
- 共招募2817名参与者,包括400名临床医生、609例SLE患者、463名对照和489例IA患者。
主要发现
- SLE患者(n=609)报告的神经精神症状患病率显著高于对照组(n=463)和IA患者(n=489)。
- SLE和IA患者的定量数据显示多种神经精神症状随关节疼痛等其他疾病症状复发/缓解。
- 超过45%的SLE患者报告疲劳、阳性感觉症状、严重头痛和认知功能障碍在使用皮质类固醇后缓解或改善。
- 与IA患者比较,SLE患者严重头痛对皮质类固醇的改善报告更多(p=0.008),随疾病活动复发/缓解更多(P < 0.001)。
关键数值与推荐
- SLE患者中超过45%报告疲劳、阳性感觉症状、严重头痛和认知功能障碍在使用皮质类固醇后缓解或改善。
- SLE患者与IA患者比较,严重头痛对皮质类固醇改善的报告更多(p=0.008),随疾病活动复发/缓解更多(P < 0.001)。
临床怎么用
- 临床医生和患者报告没有足够时间讨论患者报告的归因证据。
- 被视为间接相关/不可归因的症状往往较少被优先讨论和治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Attribution of neuropsychiatric symptoms in systemic lupus erythematosus (SLE) relies heavily on clinician assessment. Limited clinic time, variable knowledge and symptom under-reporting contribute to discordance between clinician assessments and patient symptoms. We obtained attributional data directly from patients and clinicians in order to estimate and compare potential levels of direct attribution to SLE of multiple neuropsychiatric symptoms using different patient-derived measures. METHODS: Quantitative and qualitative data analysed included: the prevalence and frequency of neuropsychiatric symptoms, response to corticosteroids and concurrence of neuropsychiatric symptoms with non-neuropsychiatric SLE disease activity. SLE patients were also compared with controls and inflammatory arthritis (IA) patients to explore the attributability of neuropsychiatric symptoms to the direct disease effects on the brain/nervous system. RESULTS: We recruited 2817 participants, including 400 clinicians. SLE patients (n = 609) reported significantly higher prevalences of neuropsychiatric symptoms than controls (n = 463) and IA patients (n = 489). SLE and IA patients' quantitative data demonstrated multiple neuropsychiatric symptoms relapsing/remitting with other disease symptoms such as joint pain. Over 45% of SLE patients reported resolution/improvement of fatigue, positive sensory symptoms, severe headache, and cognitive dysfunction with corticosteroids. Evidence of direct attributability in SLE was highest for hallucinations and severe headache. SLE patients had greater reported improvement from corticosteroids (p= 0.008), and greater relapsing-remitting with disease activity (P < 0.001) in the comparisons with IA patients for severe headache. Clinicians and patients reported insufficient time to discuss patient-reported attributional evidence. Symptoms viewed as indirectly related/non-attributable were often less prioritized for discussion and treatment. CONCLUSION: We found evidence indicating varying levels of direct attributability of both common and previously unexplored neuropsychiatric symptoms in SLE patients, with hallucinations and severe headache assessed as the most directly attributable. There may also be-currently under-estimated-direct effects on the nervous system in IA and other systemic rheumatological diseases.
引用
- Sloan M, Pollak TA, Massou E, et al. Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project. Rheumatology (Oxford). 2025. PMID: 38518094. doi:10.1093/rheumatology/keae194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。